Inactive Instrument

Highlights Flying Brands Ltd. London S.E.

Equities

IQ-AI Says Brain Cancer Drug Delays Disease Progression in Early-stage Study	Jun. 14	MT
IQ-AI team begins defining phase 2 protocol for oral gallium maltolate	Jun. 14	AN
IQ-AI Ltd. Provides Update on Phase 1 Update	Jun. 14	CI
Celadon ships to US; Oxford BioDynamics-Goodbody pact	May. 23	AN
IQ-AI subsidiary gets second FDA rare paediatric disease designation	May. 20	AN
Ingenta trades in line; Triple Point Social NAV up	May. 17	AN
IQ-AI Unit Delivers Software to Insel Gruppe	May. 17	MT
EARNINGS AND TRADING: Trident Royalties swings to profit	May. 02	AN
IQ-AI Limited Provides Revenue Guidance for the Financial Year 2024	Apr. 29	CI
IQ-AI Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
IQ-AI shares sink on discounted placing fundraise	Feb. 22	AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback	Feb. 09	MT
IQ-AI subsidiary asked by FDA to resubmit and modify application	Feb. 09	AN
IQ-AI Unit Secures Grant for Brain Tumor Pill Access Program	Feb. 02	MT
IQ-AI celebrates USD100,000 grant for subsidiary	Feb. 02	AN
IQ-AI falls after subsidiary notes launch of treatment access scheme	Jan. 10	AN
IQ-AI's Imaging Biometrics Plans Expanded Access Program for Brain Tumor Treatment	Jan. 10	MT
IQ-AI Applies for FDA Pediatric Rare Disease Designation	Nov. 08	CI
IQ-AI Unit’s Study Validates IB Neuro Platform for Reduced Gadolinium Approach on 1.5T MR Scanners	23-09-08	MT
Mayo Clinic Reverts IQ-AI Shares as IB Trax Deal Closes	23-08-18	MT

No results for this search